Lipoprotein[a] and the lipid profile in patients with systemic sclerosis

Clinica Chimica Acta

Volumn 364, Issue 1-2, 2006, Pages 345-348

  Lippi, Giuseppe ^a   Caramaschi, Paola ^b   Montagnana, Martina ^a   Salvagno, Gian Luca ^a   Volpe, Alessandro ^b   Guidi, Giancesare ^a  

^a UNIVERSITY HOSPITAL OF VERONA   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

Author keywords

Lipids; Lipoprotein a ; Lipoproteins; Scleroderma; Systemic sclerosis

Indexed keywords

C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; CHOLESTEROL; CYCLOPHOSPHAMIDE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ILOPROST; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PENICILLAMINE; TRIACYLGLYCEROL;

ADULT; ARTICLE; ATHEROGENESIS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; LIPID ANALYSIS; PATHOGENESIS; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; SYSTEMIC SCLEROSIS; TRIACYLGLYCEROL BLOOD LEVEL;

C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CREATININE; FEMALE; HUMANS; LIPIDS; LIPOPROTEIN(A); MIDDLE AGED; SCLERODERMA, SYSTEMIC; SERUM ALBUMIN; TRIGLYCERIDES;

EID: 31044448693     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2005.07.015     Document Type: Article

References (15)

1. M.S. Chandalia, C.V. Vanjani, A.R. Bhagwat, S.A. Desai, S. Sharma, and V.R. Joshi Cardiac involvement in systemic sclerosis J Assoc Physicians India 41 1993 631 632
2. M.B. Kahaleh Vascular involvement in systemic sclerosis (SSc) Clin Exp Rheumatol 223 Suppl 33 2004 S19 S23
3. Y. Zhang, L.L. McCormick, S.R. Desai, C. Wu, and A.C. Gilliam Murine sclerodermatous graft-versus-host disease, a model for human scleroderma: cutaneous cytokines, chemokines, and immune cell activation J Immunol 168 2002 3088 3098
4. E.F. Borba, C.T. Borges, and E. Bonfa Lipoprotein profile in limited systemic sclerosis Rheumatol Int 25 2005 379 383
5. P.R. Ames, S. Lupoli, and J. Alves The coagulation/fibrinolysis balance in systemic sclerosis: evidence for a haematological stress syndrome Br J Rheumatol 36 1997 1045 1050
6. S.M. Grundy, R. Pasternak, P. Greenland, S. Smith Jr., and V. Fuster Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology Circulation 100 1999 1481 1492
7. Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) JAMA 285 2001 2486 2497
8. American Rheumatism Association Subcommittee for Scleroderma. Criteria of the Therapeutic Criteria Committee, preliminary criteria for the classification of systemic sclerosis (scleroderma) Arthritis Rheum 23 1980 581 590
9. W.T. Friedewald, R.I. Levy, and D.S. Fredrickson Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge Clin Chem 18 1972 499 502
10. M. Dobiasova Atherogenic index of plasma [log(triglycerides/HDL- cholesterol)]: theoretical and practical implications Clin Chem 50 2004 1113 1115
11. G. Lippi, and G. Guidi Risk factors for cardiovascular disease CMAJ 166 2002 710
12. G. Lippi, and G. Guidi Lipoprotein(a): an emerging cardiovascular risk factor Crit Rev Clin Lab Sci 40 2003 1 42
13. G. Lippi, V. Braga, S. Adami, and G. Guidi Modification of serum apolipoprotein A-I, apolipoprotein B and lipoprotein(a) levels after bisphosphonates-induced acute phase response Clin Chim Acta 271 1998 79 87
14. M.M. Cerinic, G. Valentini, and G.G. Sorano Blood coagulation, fibrinolysis, and markers of endothelial dysfunction in systemic sclerosis Semin Arthritis Rheum 32 2003 285 295
15. S. Ferreira, D.P. D'Cruz, and G.R. Hughes Multiple sclerosis, neuropsychiatric lupus and antiphospholipid syndrome: where do we stand? Rheumatology (Oxford) 44 2005 434 442